Excerpt. Note 2013Fondaparinux was approved in July 2011 and...

Excerpt. Note 2013

Fondaparinux was approved in July 2011 and almost immediately Dr Reddy’s started to ship product. Shortly
thereafter, GSK launched an Authorized Generic (AG) through Apotex. An AG does not need to go through an
approval process as it is simply a rebadged version of the branded drug. Alchemia receives 50% of profits from
the sales of fondaparinux in the territory after certain development costs have been recouped by our partner. We
expect to start receiving profits from fondaparinux in the second half of financial year 2013 following the
repayment of those costs under the terms of our agreement. Market share in the retail segment of the market
has been strong with Dr Reddy’s now commanding a 41% share of